This study will (1) comprehensively characterize the substance use disorder (SUD) risk profile associated with adolescent Delayed Sleep Phase (DSP), and (2) probe whether SUD risk is diminished by altering sleep/circadian timing.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Weekday Sleep Duration - Actigraphy
Timeframe: T1 (1 Week), T2 (2 Weeks)
Circadian Timing - Dim Light Melatonin Onset
Timeframe: Overnight visits at end of T1 (1 Week) and T2 (2 Weeks). Always occurred on a Wednesday or Thursday.
Circadian Alignment
Timeframe: Overnight visits at end of T1 (1 Week) and T2 (2 Weeks). Always occurred on a Wednesday or Thursday. Based on DLMO assessed on weeknight lab overnight visit, and including the two nights of actigraphy data prior to the lab visit.
Reward Motivation (Behavioral)
Timeframe: Overnight visits at end of T1 (1 Week) and T2 (2 Weeks). Always occurred on a Wednesday or Thursday.
Behavioral Inhibition
Timeframe: Overnight visits at end of T1 (1 Week) and T2 (2 Weeks). Always occurred on a Wednesday or Thursday.
Neural Correlates of Reward Anticipation
Timeframe: Overnight visits at end of T1 (1 Week) and T2 (2 Weeks). Always occurred on a Wednesday or Thursday.
Neural Correlates of Reward Receipt
Timeframe: Overnight visits at end of T1 (1 Week) and T2 (2 Weeks). Always occurred on a Wednesday or Thursday.
Neural Correlates of Impulse Control
Timeframe: Overnight visits at end of T1 (1 Week) and T2 (2 Weeks). Always occurred on a Wednesday or Thursday.
Cannabis Use
Timeframe: Days of cannabis use in 3 months prior to baseline.
Alcohol Use
Timeframe: 3 months prior to baseline, based on timeline followback interview.